0
Clinical Investigations: CARDIOLOGY |

Carvedilol Reduces the Inappropriate Increase of Ventilation During Exercise in Heart Failure Patients*

Piergiuseppe Agostoni, MD, PhD, FCCP; Marco Guazzi, MD, PhD; Maurizio Bussotti, MD; Stefano De Vita, MD; Pietro Palermo, MD
Author and Funding Information

*From the Centro Cardiologico, Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto di Cardiologia, Università di Milano, Milan, Italy.

Correspondence to: Piergiuseppe Agostoni, MD, PhD, FCCP, Centro Cardiologico, Monzino, Istituto di Cardiologia, Università di Milano, via Parea 4, 20138 Milan, Italy; e-mail: Piergiuseppe.Agostoni@cardiologicomonzino.it



Chest. 2002;122(6):2062-2067. doi:10.1378/chest.122.6.2062
Text Size: A A A
Published online

Study objective: To evaluate the effects of β-blockers on ventilation in heart failure patients. Indeed, β-blockers ameliorate the clinical condition and cardiac function of heart failure patients, but not exercise capacity. Because ventilation is inappropriately elevated in heart failure patients due to overactive reflexes from ergoreceptors and chemoreceptors, we hypothesized that β-blockers can elicit their positive clinical effects through a reduction of ventilation.

Design: This was a double-blind, randomized, placebo-controlled study.

Setting: University hospital heart failure unit.

Patients and interventions: While receiving placebo (2 months) and a full dosage of carvedilol (4 months), 15 chronic heart failure patients were evaluated by quality-of-life questionnaire, pulmonary function tests, cardiopulmonary exercise tests with constant workload, and a ramp protocol.

Results: Therapy with carvedilol did not affect resting pulmonary function and exercise capacity. However, carvedilol improved the results of the quality-of-life questionnaire, reduced the mean (± SD) slope of the minute ventilation (V̇e)/carbon dioxide output (V̇co2) ratio (from 36.4 ± 8.9 to 31.7 ± 3.8; p < 0.01) and reduced ventilation at the following times: at peak exercise (from 60 ± 14 to 48 ± 15 L/min; p < 0.05); during the intermediate phases of a ramp-protocol exercise; and during the steady-state phase of a constant-workload exercise (from 42 ± 14 to 34 ± 13 L/min; p < 0.05, at third min). The end-expiratory pressure for carbon dioxide increased as ventilation decreased. The reduction in the V̇e/V̇co2 ratio was correlated with improvement in quality of life (r = 0.603; p < 0.02).

Conclusions: Improvement in the clinical conditions of heart failure patients treated with carvedilol is associated with reductions in the inappropriately elevated ventilation levels observed during exercise.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
Adults with systolic heart failure.
Michigan Quality Improvement Consortium | 7/17/2009
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543